187 related articles for article (PubMed ID: 17239629)
1. Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii.
Akyol A; Bicerol B; Ertug S; Ertabaklar H; Kiylioglu N
Seizure; 2007 Apr; 16(3):233-7. PubMed ID: 17239629
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of Toxoplasma gondii and Toxocara canis in a human rural population of Southern Rio Grande do Sul.
Araújo AC; Villela MM; Sena-Lopes Â; Farias NADR; Faria LMJ; Avila LFDC; Berne MEA; Borsuk S
Rev Inst Med Trop Sao Paulo; 2018; 60():e28. PubMed ID: 29972461
[TBL] [Abstract][Full Text] [Related]
3. Seropositivity rates for Bartonella henselae, Toxocara canis and Toxoplasma gondii in New Zealand blood donors.
Zarkovic A; McMurray C; Deva N; Ghosh S; Whitley D; Guest S
Clin Exp Ophthalmol; 2007 Mar; 35(2):131-4. PubMed ID: 17362453
[TBL] [Abstract][Full Text] [Related]
4. Seropositivity of Toxoplasma gondii and Toxocara spp. in Children with Cryptogenic Epilepsy, Benha, Egypt.
Eraky MA; Abdel-Hady S; Abdallah KF
Korean J Parasitol; 2016 Jun; 54(3):335-8. PubMed ID: 27417090
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Toxoplasma gondii and Toxocara canis among patients with uveitis.
Lim SJ; Lee SE; Kim SH; Hong SH; You YS; Kwon OW; Kim HS
Ocul Immunol Inflamm; 2014 Oct; 22(5):360-6. PubMed ID: 24833105
[TBL] [Abstract][Full Text] [Related]
6. Comment on "Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii".
Quet F; Preux PM; Nicoletti A
Seizure; 2008 Apr; 17(3):296. PubMed ID: 17977752
[No Abstract] [Full Text] [Related]
7. Seroprevalence and risk factors associated with zoonotic parasitic infections in small ruminants in the Greek temperate environment.
Kantzoura V; Diakou A; Kouam MK; Feidas H; Theodoropoulou H; Theodoropoulos G
Parasitol Int; 2013 Dec; 62(6):554-60. PubMed ID: 23994572
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Toxoplasma and Toxocara antibodies among out-patients in the Ophthalmic Research Institute, Egypt.
Safar EH; Abd-el Ghaffar FM; Saffar SA; Makled KM; Habib KS; el Abiad R; el Shabrawy E
J Egypt Soc Parasitol; 1995 Dec; 25(3):839-52. PubMed ID: 8586877
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Toxoplasma gondii and Toxocara canis among Patients with Uveitis.
Lim SJ; Lee SE; Kim SH; Hong SH; You YS; Kwon OW; Kim HS
Ocul Immunol Inflamm; 2015 Apr; 23(2):111-7. PubMed ID: 24131311
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii and Toxocara spp. co-infection.
Jones JL; Kruszon-Moran D; Won K; Wilson M; Schantz PM
Am J Trop Med Hyg; 2008 Jan; 78(1):35-9. PubMed ID: 18187782
[TBL] [Abstract][Full Text] [Related]
11. Epilepsy and toxocariasis: a case-control study in Italy.
Nicoletti A; Sofia V; Mantella A; Vitale G; Contrafatto D; Sorbello V; Biondi R; Preux PM; Garcia HH; Zappia M; Bartoloni A
Epilepsia; 2008 Apr; 49(4):594-9. PubMed ID: 18031545
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of toxoplasmosis, toxocariasis and cysticercosis in a rural settlement, São Paulo State, Brazil.
Prestes-Carneiro LE; Rubinsky-Elefant G; Ferreira AW; Araujo PR; Troiani C; Zago SC; Kaiahara M; Sasso L; Iha A; Vaz A
Pathog Glob Health; 2013 Mar; 107(2):88-95. PubMed ID: 23683335
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of ocular toxocariasis by establishing intraocular antibody production.
de Visser L; Rothova A; de Boer JH; van Loon AM; Kerkhoff FT; Canninga-van Dijk MR; Weersink AY; de Groot-Mijnes JD
Am J Ophthalmol; 2008 Feb; 145(2):369-74. PubMed ID: 18061138
[TBL] [Abstract][Full Text] [Related]
14. SERO-PREVALENCE OF ANTI- TOXOPLASMA GONDII ANTIBODIES AMONG PATIENTS WITH NEUROPSYCHIATRIC DISORDERS: EPILEPSY AND DEPRESSION.
Abd El-Aal NF; Saber M; Fawzy N; Ashour WR
J Egypt Soc Parasitol; 2016 Dec; 46(3):729-736. PubMed ID: 30230768
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia.
Emelia O; Amal RN; Ruzanna ZZ; Shahida H; Azzubair Z; Tan KS; Noor Aadila S; Siti NA; Aisah MY
Trop Biomed; 2012 Mar; 29(1):151-9. PubMed ID: 22543615
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy and toxocariasis: a case-control study in Burundi.
Nicoletti A; Bartoloni A; Sofia V; Mantella A; Nsengiyumva G; Frescaline G; Preux PM
Epilepsia; 2007 May; 48(5):894-9. PubMed ID: 17508999
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of
Saki J; Mowla K; Arjmand R; Kazemi F; Fallahizadeh S
Infect Disord Drug Targets; 2021; 21(1):43-48. PubMed ID: 31889500
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of IgG anti-Toxocara canis antibodies and anti-Fasciola sp. antibodies in patients with urticaria.
Dal T; Ciçek M; Uçmak D; Akkurt M; Tekin A; Dal MS; Tekin R; Kalkanl ST
Clin Ter; 2013; 164(4):315-7. PubMed ID: 24045514
[TBL] [Abstract][Full Text] [Related]
19. Toxocara seroprevalence in patients with idiopathic Parkinson's disease: chance association or coincidence?
Çelik T; Kaplan Y; Ataş E; Öztuna D; Berilgen S
Biomed Res Int; 2013; 2013():685196. PubMed ID: 23509761
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with toxoplasmosis and toxocariasis in populations of children from nine cities in southern Brazil.
Marchioro AA; Colli CM; Ferreira ÉC; Viol BM; Araújo SM; Falavigna-Guilherme AL
J Helminthol; 2015 Jul; 89(4):428-32. PubMed ID: 24725417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
